Chemoinformaics analysis of 16-Acetoxy-7-O-Acetylhorminone
| Molecular Weight | 432.513 | nRot | 4 |
| Heavy Atom Molecular Weight | 400.257 | nRig | 19 |
| Exact Molecular Weight | 432.215 | nRing | 3 |
| Solubility: LogS | -3.88 | nHRing | 0 |
| Solubility: LogP | 5.003 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 67.0314 |
| nHD | 1 | BPOL | 39.0466 |
| QED | 0.272 |
| Synth | 4.478 |
| Natural Product Likeliness | 2.243 |
| NR-PPAR-gamma | 0.387 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.074 |
| Pgp-sub | 0.015 |
| HIA | 0.271 |
| CACO-2 | -4.936 |
| MDCK | 0.0000232 |
| BBB | 0.295 |
| PPB | 0.885217 |
| VDSS | 1.562 |
| FU | 0.243804 |
| CYP1A2-inh | 0.085 |
| CYP1A2-sub | 0.109 |
| CYP2c19-inh | 0.083 |
| CYP2c19-sub | 0.226 |
| CYP2c9-inh | 0.492 |
| CYP2c9-sub | 0.903 |
| CYP2d6-inh | 0.08 |
| CYP2d6-sub | 0.144 |
| CYP3a4-inh | 0.225 |
| CYP3a4-sub | 0.481 |
| CL | 1.626 |
| T12 | 0.685 |
| hERG | 0.01 |
| Ames | 0.015 |
| ROA | 0.518 |
| SkinSen | 0.638 |
| Carcinogencity | 0.8 |
| EI | 0.524 |
| Respiratory | 0.936 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.811685 |